Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydr o-1-napthalenamine and its formamide
Details for Australian Patent Application No. 2003272460 (hide)
International Classifications
Event Publications
22 January 2004 Complete Application Filed
Priority application(s): 60/411,305 16.09.02 US; 60/411,304 16.09.02 US
20 May 2004 Application Open to Public Inspection
Published as AU-B-2003272460
7 April 2005 Amendment Made
The nature of the amendment is: Amend the name of the applicant to Sepracor Inc.
13 October 2005 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 09 Sep 2005
17 December 2009 Application Accepted
Published as AU-B-2003272460
29 April 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser